Safety Alerts & Recalls

What does this mean?

If you are taking Raptiva, you should contact your physician right away to discuss how to transition to an alternative treatment for your psoriasis.

Withdrawal of Raptiva (efalizumab) From the U.S. Market

Genentech announced that it has begun a phased withdrawal of Raptiva (efalizumab) from the U.S. market. The product is being withdrawn because patients are at risk for developing a rare, serious infection that may affect the brain called progressive multifocal leukoencephalopathy (PML). By June 8, 2009, Raptiva will no longer be available in the United States.

For more information, please visit: more information here

Source: Manufacturer
Publication Date: 2009-04-09
Last Updated: 2009-12-05

Visit the medication page for the following drugs:

Share your story Share your story! Tell us how MediGuard has helped you or someone you love. Mobile graphic Download the MediGuard Mobile App to manage your prescription and over-the-counter medications, for free. Registration Info Taking multiple medications puts you at risk for possible drug-drug interactions Registration Info Monitor the medical treatment of you and your loved ones.